This Fall, the dramatic story of the married scientists who founded BioNTech and developed the first vaccine against the COVID-19 pandemic will be told in THE VACCINE: Inside the Race to Conquer the COVID-19 Pandemic.
Written by Financial Times journalist Joe Miller with contributions from Dr. Sahin and Dr. Türeci–BioNTech founders and first to produce the vaccine–the book will tell the thrilling, dramatic story of one of the most important medical breakthroughs of our age. THE VACCINE will reveal how they were able to develop a panel of vaccine candidates within a matter of weeks, how they convinced major pharmaceutical companies to support their work, how they navigated negotiations with the U.S. administration and the European Union, and how in partnership with Pfizer they managed to produce more than two billion doses for countries around the world. Drs Sahin and Türeci will explain the 30 years of scientific research that laid the foundations for the first Covid-19 vaccine, at a time when public confidence in its safety and efficacy is crucial to offering humanity a route out of this pandemic. And, they will offer a glimpse into the potential treatment of other diseases that the success of the BioNTech vaccine offers.
George Witte said, “I’m honored to be publishing this important book by Joe Miller with contributions from Dr. Sahin and Dr. Türeci, which takes us behind the scenes of the most urgent story of our time and shows how science triumphs over panic, politics, and misinformation to begin to solve a global crisis.”
Joe Miller said: “Having watched the record-breaking development of the world’s first clinically approved Covid-19 vaccine at close quarters, I am delighted to be able to tell the story of what will surely rank as one of the greatest scientific achievements of our age. In their longstanding quest to target cancer, Ugur Sahin and Özlem Türeci, believed in harnessing the powers of the immune system. Their triumph, at one of humankind’s darkest moments, was no happy accident. As this account will explain, it was built on decades spent in perseverant pursuit of a single vision, one that now promises to unlock a new generation of vaccines and therapies.”